Compare BLLN & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | SYM |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.3B |
| IPO Year | 2025 | 2021 |
| Metric | BLLN | SYM |
|---|---|---|
| Price | $109.83 | $37.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $129.00 | $61.50 |
| AVG Volume (30 Days) | 456.0K | ★ 1.6M |
| Earning Date | 11-04-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.40 | N/A |
| EPS | ★ 0.48 | 0.12 |
| Revenue | $305,112,000.00 | ★ $2,246,922,000.00 |
| Revenue This Year | $49.33 | $24.53 |
| Revenue Next Year | $26.38 | $28.42 |
| P/E Ratio | ★ $237.01 | $315.29 |
| Revenue Growth | ★ 99.97 | 25.65 |
| 52 Week Low | $61.96 | $36.02 |
| 52 Week High | $150.44 | $87.88 |
| Indicator | BLLN | SYM |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 40.73 |
| Support Level | $89.26 | N/A |
| Resistance Level | $127.72 | $44.26 |
| Average True Range (ATR) | 5.53 | 2.12 |
| MACD | 1.15 | -0.20 |
| Stochastic Oscillator | 60.41 | 27.40 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.